Home Table of Contents

§ 15-1617. Policies and procedures of pharmacy and therapeutics committee

West's Annotated Code of MarylandInsuranceEffective: October 1, 2008

West's Annotated Code of Maryland
Insurance (Refs & Annos)
Title 15. Health Insurance
Subtitle 16. Pharmacy Benefits Managers (Refs & Annos)
Part III. Pharmacy and Therapeutics Committees
Effective: October 1, 2008
MD Code, Insurance, § 15-1617
§ 15-1617. Policies and procedures of pharmacy and therapeutics committee
Currentness
A pharmacy benefits manager shall ensure that its pharmacy and therapeutics committee has:
(1) policies and procedures, including disclosure requirements, to address potential conflicts of interest that members of the pharmacy and therapeutics committee may have with developers or manufacturers of prescription drugs;
(2) a process to evaluate medical and scientific evidence concerning the safety and effectiveness of prescription drugs, including available comparative information on clinically similar prescription drugs, when deciding what prescription drugs to recommend to include on a formulary;
(3) a process to evaluate medical and scientific evidence concerning the safety and effectiveness of prescription drugs when recommending utilization review requirements, dose restrictions, and step therapy requirements; and
(4) a process to enable the pharmacy and therapeutics committee to consider the need to recommend a formulary change to a purchaser in a timely manner but at least annually.

Credits

Added by Acts 2008, c. 279, § 1, eff. Oct. 1, 2008.
MD Code, Insurance, § 15-1617, MD INSURANCE § 15-1617
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document